Suvretta Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49.5M | Buy |
|
|||||
|
2025
Q2 | $35M | Buy |
|
|||||
|
2025
Q1 | $14.6M | Buy |
|
|||||
|
2024
Q4 | $15.7M | Buy |
|
|||||
|
2024
Q3 | $4.22M | Sell |
|
|||||
|
2024
Q2 | $15.8M | Sell |
|
|||||
|
2024
Q1 | $26.9M | Sell |
|
|||||
|
2023
Q4 | $37.3M | Sell |
|
|||||
|
2023
Q3 | $25.4M | Hold |
|
|||||
|
2023
Q2 | $18.9M | Buy |
|
|||||
|
2023
Q1 | $14.8M | Buy |
|
|||||
|
2022
Q4 | $31.1M | Buy |
|
|||||
|
2022
Q3 | $28.5M | Buy |
|
|||||
|
2022
Q2 | $16.4M | Buy |
|
|||||
|
2022
Q1 | $61.8M | Buy |
|
|||||
|
2021
Q4 | $42M | Buy |
|
|||||
|
2021
Q3 | $54.8M | Buy |
|
|||||
|
2021
Q2 | $17.1M | Buy |
|
|||||
|
2021
Q1 | $18M | Buy |
|